Measles Vaccine,Live (Lanzhou Institute Of Biological Products)

麻疹减毒活疫苗（兰州生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeasles Vaccine,Live (Lanzhou Institute Of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeasles

Global Approved IndicationsMeasles

Approved Indications in ChinaMeasles

Original Approved Country/TerritoryMainland China

Original Approved Date1982/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesLanzhou Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesLanzhou Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsMeasles

Inactive IndicationsN/A

Other Information

ATC CodeJ07BD01